PH14458A - Process for isolating the immunogenic components of influenza viruses - Google Patents

Process for isolating the immunogenic components of influenza viruses

Info

Publication number
PH14458A
PH14458A PH16702A PH16702A PH14458A PH 14458 A PH14458 A PH 14458A PH 16702 A PH16702 A PH 16702A PH 16702 A PH16702 A PH 16702A PH 14458 A PH14458 A PH 14458A
Authority
PH
Philippines
Prior art keywords
isolating
influenza viruses
immunogenic components
immunogenic
components
Prior art date
Application number
PH16702A
Other languages
English (en)
Inventor
G Schmidt
H Bachmayer
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of PH14458A publication Critical patent/PH14458A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
PH16702A 1974-01-14 1975-01-13 Process for isolating the immunogenic components of influenza viruses PH14458A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (de) 1974-01-14 1974-01-14

Publications (1)

Publication Number Publication Date
PH14458A true PH14458A (en) 1981-07-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
PH16702A PH14458A (en) 1974-01-14 1975-01-13 Process for isolating the immunogenic components of influenza viruses

Country Status (27)

Country Link
JP (2) JPS58407B2 (de)
AT (1) AT345449B (de)
AU (1) AU500250B2 (de)
BE (1) BE824372A (de)
CA (1) CA1049406A (de)
CH (1) CH589453A5 (de)
CS (1) CS191254B2 (de)
DD (1) DD116239A5 (de)
DE (1) DE2500785B2 (de)
DK (1) DK140003B (de)
ES (1) ES433759A1 (de)
FI (1) FI54053C (de)
FR (1) FR2257305B1 (de)
GB (1) GB1498261A (de)
HK (1) HK56380A (de)
HU (1) HU173920B (de)
IE (1) IE40794B1 (de)
IL (1) IL46426A (de)
MY (1) MY8100204A (de)
NL (1) NL166622C (de)
NO (1) NO143128C (de)
PH (1) PH14458A (de)
PL (1) PL93689B1 (de)
SE (1) SE427238B (de)
SU (1) SU616997A3 (de)
YU (1) YU41289B (de)
ZA (1) ZA75259B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (de) 1997-11-25 1999-06-02 Duphar International Research B.V Impfstoff, dessen Adjuvant aus B-Untereinheiten des hitzelabilen Enterotoxins (LTB) von Escherichiacoli besteht
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
PT2301572E (pt) * 2005-11-01 2014-12-22 Novartis Vaccines & Diagnostic Vacinas virais derivadas de células com níveis baixos de adn celular residual
CN101790381B (zh) * 2007-08-28 2014-08-27 巴克斯特国际公司 生产病毒疫苗的方法
AU2014350370B2 (en) 2013-11-15 2017-04-13 Novartis Ag Removal of residual cell culture impurities

Also Published As

Publication number Publication date
DK140003C (de) 1979-10-29
YU41289B (en) 1987-02-28
GB1498261A (en) 1978-01-18
DD116239A5 (de) 1975-11-12
JPS6035326B2 (ja) 1985-08-14
IE40794L (en) 1975-07-14
NL166622C (nl) 1981-09-15
FI54053B (fi) 1978-06-30
PL93689B1 (de) 1977-06-30
DE2500785C3 (de) 1980-09-11
IE40794B1 (en) 1979-08-15
YU5875A (en) 1984-04-30
IL46426A (en) 1978-01-31
SU616997A3 (ru) 1978-07-25
AU500250B2 (en) 1979-05-17
NO143128C (no) 1980-12-29
BE824372A (fr) 1975-07-14
NL166622B (nl) 1981-04-15
NL7500301A (nl) 1975-07-16
ATA21475A (de) 1978-01-15
NO750031L (de) 1975-08-11
JPS50100224A (de) 1975-08-08
FI750014A (de) 1975-07-15
NO143128B (no) 1980-09-15
CS191254B2 (en) 1979-06-29
DE2500785A1 (de) 1975-07-31
MY8100204A (en) 1981-12-31
SE427238B (sv) 1983-03-21
IL46426A0 (en) 1975-04-25
HK56380A (en) 1980-10-16
AT345449B (de) 1978-09-11
FR2257305A1 (de) 1975-08-08
FR2257305B1 (de) 1982-03-19
HU173920B (hu) 1979-09-28
FI54053C (fi) 1978-10-10
ES433759A1 (es) 1977-02-16
DK140003B (da) 1979-06-05
ZA75259B (en) 1976-08-25
DE2500785B2 (de) 1980-01-03
JPS58407B2 (ja) 1983-01-06
CA1049406A (en) 1979-02-27
AU7730575A (en) 1976-07-15
JPS56127319A (en) 1981-10-06
CH589453A5 (de) 1977-07-15
DK1475A (de) 1975-09-01
SE7500130L (de) 1975-07-15

Similar Documents

Publication Publication Date Title
CH612425A5 (en) Process for the preparation of novel 2-tetrahydrofurfuryl-6,7-benzomorphans
YU39471B (en) Process for the manufactue of new 1-thiazolylimidazolidinones
PH14458A (en) Process for isolating the immunogenic components of influenza viruses
ZA757118B (en) Process for the preparation of addition agents
ZA752394B (en) Process for the isolation of gama-l-glutamyl-taurine
CH613193A5 (en) Process for the preparation of novel 2-arylamino-2-imidazoline derivatives
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
CH613683A5 (en) Process for the preparation of secoprostaglandins
ZM11375A1 (en) Process for the preparation of poly-(-n-alkyliminoalanes)
ZA75976B (en) Process for the preparation of cis-vincamine
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
CH611273A5 (en) Process for the preparation of novel 3-oxocyclohex-1-en-1-yl- ureas
CH614935A5 (en) Process for the preparation of novel 9-thia-, 9-oxothia- and 9-dioxothia-11,12-secoprostaglandins
EG11656A (en) Process for the preparation of propanolamin derivatives
IL46698A (en) Process for the preparation of 7-amino-delta3-cephem derivatives
CH614443A5 (en) Process for the preparation of 1-thiadiazolyl-6-acyloxytetrahydropryrimidinones
CH613693A5 (en) Process for the preparation of trisaminopyridines
IL48633A (en) Process for the preparation of trichlorothiazole
GB1518104A (en) Process for the preparation of 2-hydrocarbylglycerols
IL47243A (en) Process for the preparation of 4-hydroxypyrimidines
CH614712A5 (en) Process for the preparation of the novel alpha-amino-2-adamantylmethylpenicillin
CH614192A5 (en) Process for the preparation of substituted triphenylethylenes
GB1408129A (en) Process for the preparation of alkyl cyclohexanones
CH614933A5 (en) Process for the preparation of novel amines
CH613457A5 (en) Process for the preparation of 7-methoxycephalosporin derivatives